CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities
Net income	$ 25,886	$ 16,136
Adjustments to reconcile net income to net cash provided by operating activities
Provision for loan losses	586	10,700
Depreciation and amortization	1,490	1,631
Provision for loss on premises held for sale	25	0
Loans originated for resale	(5,135)	0
Proceeds from Sale of Loans Held-for-sale	5,239	0
Net gain on sale of loans held for sale	(85)	0
Loss on sale of loans	191	0
Net (gain) loss on the sale of OREO	(17)	9
Gains on sales of investment securities	(586)	(1,384)
Unrealized loss (gain) on equity securities	139	(101)
Gain on sale of assets	(68)	(6)
Net amortization of premium/discount on investment securities	1,266	163
Net accretion of premiums and discounts	(417)	(605)
Amortization of debt issuance costs	(16)	10
Amortization of core deposit intangible	495	591
Amortization of right of use asset	395	551
Net change in right of use assets and lease liabilities	(377)	(407)
Increase in OREO valuation allowance	1,387	3,022
Increase in cash surrender value of bank owned life insurance	(871)	(881)
Decrease (increase) in deferred income tax benefit	1,151	(2,757)
Decrease (increase) in accrued interest receivable	3,129	(3,698)
Stock based compensation	761	396
Net change due to deficit of fair market value below cost of leveraged ESOP shares released	2	(39)
Decrease in net deferred loan costs	2,565	2,975
(Decrease) increase in accrued expenses and other liabilities	(2,983)	568
(Increase) decrease in other assets	(935)	1,209
Net Cash Provided by Operating Activities	33,217	28,083
Cash Flows from Investing Activities
Purchase of AFS investment securities	(327,693)	(149,426)
Proceeds from redemption or principal payments of AFS investment securities	53,952	40,952
Proceeds from sale of AFS investment securities	12,540	75,711
Net decrease of FHLB and FRB stock	1,305	670
Net change in loans	(7,625)	(163,271)
Purchase of premises and equipment	(2,645)	(255)
Proceeds from sale of OREO	1,739	2,872
Proceeds from sale of loans	11,965	0
Proceeds from disposal of asset	416	21
Net Cash Used in Investing Activities	(256,046)	(192,726)
Cash Flows from Financing Activities
Net increase in deposits	310,562	233,765
Proceeds from long-term debt	0	164,036
Payments of long-term debt	(15,071)	(177,104)
Net decrease in short term borrowings	0	(5,000)
Proceeds from subordinated notes - 4.75%	0	19,516
Payments of subordinated notes - 6.25%	0	(23,000)
Dividends paid	(3,170)	(2,819)
Net change in unearned ESOP shares	143	143
Repurchase of common stock	(7,046)	(298)
Net Cash Used by Financing Activities	285,418	209,239
Increase in Cash and Cash Equivalents	62,589	44,596
Cash and Cash Equivalents - January 1	77,065	32,469
Cash and Cash Equivalents - December 31	139,654	77,065
Cash paid during the period for
Interest	4,386	9,072
Income taxes	8,119	7,133
Supplemental Schedule of Non-Cash Operating Activities
Issuance of common stock for payment of compensation	220	303
Transfer from loans to OREO	$ 0	$ 1,240